US Rejects Nigeria's Request For Trial Ebola Drug.

The United States of America, yesterday, dashed the hope of an early cure for Ebola Virus victims in Nigeria when it refused to share the trial drug with Nigeria. US President Barak Obama says it would be premature to share the experimental drug with Africa. The Federal Government had earlier reached out to the United States Centre for Disease Control and Prevention, CDC, in Atlanta, to request for the drug for treatment of EVD affected persons in Nigeria, but President Obama turned down the request, saying it would be far more beneficial to focus on prevention instead. Nigeria recorded its first Ebola Virus disease fatality on Tuesday when one of the nurses who was one of the primary contacts of the American-Liberian, Patrick Sawyer, passed on. The doctor who treated Sawyer, who died in the country after flying into Lagos, is now ill with Ebola and six other primary contacts are currently ill with the disease in a Lagos hospital where they are quarantined. Minister of Health, Professor Onyebuchi Chukwu and Minister of Information, Mr. Labaran Maku had disclosed on Wednesday after the Federal Executive Council meeting in Abuja that the Federal Government was awaiting the response of the request it made to the CDC on Tuesday. Addressing the 50 African leaders at the US-African Summit in Washington, President Obama stated that it is “premature” to send an experimental medicine for the treatment of Ebola to West Africa, as he lacked enough information to approve the drug that was already being used on two American aid workers whose conditions were said to have improved by varying degrees. “We’ve got to let the science guide us and I don’t think all the information is in on whether this drug is helpful. The Ebola virus, both currently and in the past, is controllable if you have a strong public health infrastructure in place. “The countries affected are the first to admit that what’s happened here is the public health systems have been overwhelmed. They weren’t able to identify and then isolate cases quickly enough. “As a consequence, it spread more rapidly than has been typical with the periodic Ebola outbreaks that occurred previously,” he remarked. It might be fairer to say that outbreaks in the DR Congo and Uganda were containable because the cases were in remote regions and couldn't travel far, not because those countries have "strong public health infrastructure." Still, it's probably wise not to treat ZMapp as a miracle cure, and especially wise not to treat Ebola patients as experimental animals. Under the excellent conditions in Atlanta, even the two American cases treated with the drug may not owe their improvement to it.